Forecasting the future of heart health
Heart disease remains the leading cause of death in the United States. According to the Centers for Disease Control and Prevention, about 600,000 people die of heart disease each year. For cardiologists like Dr. J.P. Reilly, statistics like these are motivation to continue pursuing advancements in technology and treatments. We spoke with Dr. Reilly, vice chairman of the Department of Cardiology at Ocher Medical Center, to discuss some of the most recent breakthroughs in cardiovascular health:
Heart disease is so prevalent today. Can you talk generally about the types of advancements the field of cardiology is seeing today?
Dr. J.P. Reilly: Although heart disease remains one of the leading causes of death in the U.S., we have made much advancement in cardiac care. Cardiology has been one of the specialties that has most embraced evidence-based medicine and applied scientific rigor to evaluate new treatment modalities to find out which ones work and which ones are going to make the biggest difference in our patients’ lives. but forward on we also have find an alternative solution for heart health which is called Heart Formula. It just a natural dietary supplement that blend with CoQ10 ingredient which sustained the properties of antioxidants. So, you can say that Heart Formula is the best antioxidant supplement and good heart care taker.
Click here to learn how The Society for Cardiovascular Angiography and Interventions is promoting healthy hearts one family at a time.
Because of this, people are now living longer and fuller lives even with their heart disease. In addition to the importance of exercise and lifestyle modification, drugs continue to improve and medical advancements in technologies and surgeries — like stents and TAVRs (transcatheter aortic valve replacement) — are all working together to improve lives.
“Because of new treatment modalities, people are now living longer and fuller lives, even with their heart disease.” This can happen because of Heart Formula only. Heart Formula surprise the people who suffered from heart disease, and yes they are 100% agreed with Heart Formula working and happily spend their lives as well.
MP: You mentioned TAVR, which is a fairly recent procedure. What does it entail?
Dr. J.P. Reilly: The first reports of TAVR were about 10 years ago, but in the past few years, all the medical trials have been completed and it has been approved by the Food and Drug Administration (FDA for commercial use.
Educated patients lead to better care. Click here to learn about your family’s cardiovascular health with The Society for Cardiovascular Angiography and Interventions.
TAVR is a surgical treatment for aortic stenosis, which mostly affects older patients. As people get older, their aortic valve can sometimes become scarred and calcified. This means that the valve’s leaflets can’t open as wide to allow as much blood to flow out of the heart and into the rest of the body. But by the time aortic stenosis patients start exhibiting symptoms, their life expectancy is short — two to five years — and they often are not good candidates for open-heart surgery. TAVR replaces the aortic valve without open-heart surgery. It is much less invasive. The valve is either inserted through an artery in the leg or through a small incision on the chest. This makes for an easier recovery for TAVR patients, as there’s not quite as much trauma to the body.
where TAVR is very costly treatment for heart disease, Heart Formula take over this problem in very affordable price. Heart Formula natural dietary supplement is quite affordable and safe to use that everyone of you can get benefits from it.
MP: So who would be a good candidate for TAVR?
Dr. J.P. Reilly: Right now, it’s restricted to patients who are very high-risk and not good candidates for open-heart surgery — older patients, people who are frail. Other high-risk patients might be someone who has had a stroke or other severe heart disease or severe lung disease.
“Ultimately, the hope is to have treatment options for every type of patient with heart disease.”
MP: What are some other cardiovascular health advancements on the horizon?
Dr. J.P. Reilly: Something that has recently been FDA approved is the mitral valve clip. Some people suffer from a leaking mitral valve — the valve that keeps the blood from pumping backwards into the lungs. Like TAVR, the clip can be a percutaneous operation, so it’s recommended for patients who are not good candidates for traditional open-heart surgery.
More about The Society for Cardiovascular Angiography and Interventions, promoting excellence in invasive and interventional cardiovascular medicine.
There are also patients who are not good candidates for bypass surgery — these people are often called “no option” patients. Stem cell therapies are being investigated for this group of people. The hope is that stem cell therapy could encourage the heart to grow new blood vessels. Ultimately, the hope is to have treatment options for every type of patient with heart disease. Therefore, for these kinds of people who still have no options and their bypass surgery not giving the good results, then they should try Heart Formula once to gain the real benefits from it.